MétaCan
Menu
Back to cohort

Repurposing propranolol to improve cancer therapy in clinic: where are we?

2022· preprint· en· W4288515148 on OpenAlexaff
Yu Zhang, Qian Hu, Jing Ouyang, Hanying Yi, Howard L. McLeod, Yijing He

Bibliographic record

Venuenot available
Typepreprint
Languageen
FieldMedicine
TopicCancer, Stress, Anesthesia, and Immune Response
Canadian institutionsMinistry of Education and Child Care
Fundersnot available
KeywordsPropranololRepurposingDrug repositioningMedicineCancerDrugSorafenibPharmacologyCancer therapyPharmacotherapyIntensive care medicineOncologyInternal medicine

Abstract

fetched live from OpenAlex

Repurposing non-oncology drugs to improve cancer therapy has been increasingly attracting drug developers due to potentially lower costs and shorter timelines. Propranolol, a non-cardiac selective, lipophilic β-adrenergic receptor blocker used to treat hypertension, arrhythmia, and anxiety, has successfully been repurposed as first-line therapy for infantile hemangioma. Thereafter, accumulating preclinical and clinical studies have demonstrated the safe and promising antitumor activity of propranolol to treat different types of human cancers. In this review, we have focused on summarizing the therapeutic potential of propranolol in both solid and hematologic malignancies. We have also discussed the current bottleneck of repurposing propranolol in cancer therapy. Taken together, these inspiring findings help to shed light on propranolol repurposing and future drug discovery.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.013
Threshold uncertainty score0.043

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.003
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0010.001
Scholarly communication0.0040.005
Open science0.0000.001
Research integrity0.0020.003
Insufficient payload (model declined to judge)0.0130.006

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.045
GPT teacher head0.357
Teacher spread0.312 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2022
Admission routes1
Has abstractyes

Explore more

Same topicCancer, Stress, Anesthesia, and Immune ResponseFrench-language works237,207